Table 2.
Clinical and CSF characteristics in VPSV and VPSWOV patients pre-operation
| Characteristic | VPSV (n = 13) | VPSWOV (n = 10) | P |
|---|---|---|---|
| Sex(M/F) | 12/1 | 6/4 | 0.127 |
| Age(Y) median (range) | 28(17–53) | 41(17–61) | 0.032 |
| Symptoms duration, days, median (range) |
90 (20–180) | 30(10–180) | 0.019 |
| headache | 11/13 (84.6%) | 10(100%) | 0.486 |
| fever | 7/13(53.8%) | 5/10(50%) | >0.999 |
| Vomiting | 8/13(61.5%) | 8/10(80%) | 0.405 |
| Visual symptoms | 7/13(53.8%) | 7/10(70%) | 0.669 |
| Auditory symptom | 2/13(15.4%) | 3/10(30%) | 0.618 |
| Altered mental status | 5/13(38.5%) | 3/10(30%) | >0.999 |
| Seizure | 1/13(7.69%) | 2/10(20%) | 0.560 |
| Indian ink smear (+) | 12/13(92.3%) | 10/10(100%) | >0.999 |
| CSF culture positive (+) | 8/13(61.5%) | 7/10(70%) | >0.999 |
| Time to operation(m) | 3.5(1.5–6) | 2(0.5–4) | 0.028 |
| CSF pressure (mmH2O) median (range) | 330(200–1020) | 330(204–660) | 0.059 |
| WBC count(×106/l) median (range) | 60(0–550) | 36(1–496) | 0.225 |
| Protein, g/L median (range) | 0.53(0.12–4.06) | 0.8(0.23–1.62) | 0.139 |
| Glucose(mmol/l) median (range) | 2.33(0.01–5.58) | 2.53(0.23–5.7) | 0.753 |
| Chloride(mmol/l) median (range) | 118(103–133) | 120(108–136) | 0.150 |
| India ink Cryptococcus count | 23(0–1.3E4) | 1.94E3(4–1.67E5) | 0.001 |
M male, F female, CSF cerebrospinal fluid, P VPSV versus VPSWOV pre-operation